ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
Martínez-Chamorro
Carmen
C
C/ General Oraá, 3-1, 28006- Madrid SPAIN. m-chamorro@navegalia.com
Martínez
Elena
E
Gil-Fernández
Juan José
JJ
Alonso
Aránzazu
A
Escudero
Antonio
A
Fernández-Rañada
José Maria
JM
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D009220:Myositis / Q000139:chemically induced* / Q000188:drug therapy; D016463:Sweet Syndrome / Q000139:chemically induced; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D014212:Tretinoin; D003907:Dexamethasone